Abstract
Background
Malaria is a significant public health issue in sub-Saharan Africa, accounting for 96% of global malaria-related deaths. Malaria during pregnancy can lead to maternal morbidity and death, stillbirths, and newborn deaths. Prevention and control policies in areas of stable transmission emphasize a combination of intermittent preventive treatment during pregnancy (IPTp) and use of insecticide-treated nets (ITNs), along with effective case management. Neither ITNs nor IPTp provide complete protection alone, and since IPTp and ITNs work synergistically, combining these interventions could be highly effective. The World Health Organization (WHO) recommends that pregnant women receive IPTp, starting early in the second trimester, with at least three doses, regardless of ITN use. Therefore, this study aims to assess the utilization of ITNs and IPTp and the factors influencing their use among pregnant women in sub-Saharan Africa.
Methods
We used the most recent Malaria Indicator Survey (MIS) or Demographic and Health Survey (DHS) data from 18 sub-Saharan African (SSA) countries, conducted between 2018 and 2024. A weighted sample of 63,561 women who had given birth in the 3 years preceding the survey was included in this analysis. Pooled estimates for the utilization of both insecticide-treated nets (ITN) and IPTp were reported with 95% confidence intervals (CI). To determine factors associated with utilization, we performed a multilevel multinomial regression analysis. Variables with a p-value < 0.05 or whose ARRR confidence interval did not include one were considered significant factors associated with malaria preventive measures utilization among pregnant women.
Results
Among our weighted sample of 63,561 pregnant women, the following utilization rates of malaria preventive measures were observed: 28.9% (95% CI 28.4, 29.3%) used both an ITN (slept under one the previous night) and IPTp (3 or more doses), and 17.6% (95% CI 17.2, 18.0%) used neither ITN nor IPTp. Multilevel multinomial regression analysis revealed that age, educational status, sex of household head, wealth index, mass media exposure, residence and sub-region of SSA were significant factors associated with ITN and IPTp utilization.
Conclusion
Fewer than one-third of expectant mothers took advantage of combined ITN and IPTp malaria prevention strategies. Both community-level and individual-level predictors should be considered when developing strategies and implementing programs run by both governmental and non-governmental organizations in order to achieve the global goal of reducing malaria by 90% by 2030.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12936-026-05970-5.
Keywords: Malaria prevention, Pregnancy, ITN and IPTp, Sub-Sahara Africa
Background
Malaria remains a major public health problem in sub-Saharan Africa (SSA). According to the World Malaria Report 2024, the WHO African Region accounted for about 94% of global malaria cases and 95% of malaria deaths [1]. Household survey data from 19 SSA countries further show a malaria prevalence of 22.5% [2]. In high-transmission African countries, an estimated 12.4 million pregnancies (34%) were exposed to malaria infection. By sub-region, West Africa had the highest number of malaria-exposed pregnancies, followed by Central Africa [1]. Placental malaria affected 28% of malaria cases among pregnant women in the SSA region [3].
The African region accounts for the highest share of malaria deaths worldwide [4]. About 95% of global malaria deaths occur in this region [1]. Malaria in pregnancy contributes to 10,000 maternal deaths each year [5]. It is responsible for an estimated 100,000 newborn deaths globally, including 11% of newborn deaths and 20% of stillbirths in sub-Saharan Africa [6–8].
The current WHO recommendation for malaria prevention and control during pregnancy in areas of stable transmission emphasizes a package of intermittent preventive treatment during pregnancy (IPTp), use of insecticide-treated net (ITN), and ensuring effective case management of malaria illness and anemia [9]. According to WHO recommendations, IPTp should be administered to pregnant women starting early in the second trimester, with at least three doses in areas of moderate to high malaria transmission. Since ITNs alone cannot provide complete protection against malaria, IPTp-SP is not a replacement but rather a complementary intervention. Both ITNs and IPTp-SP offer important benefits and work synergistically to reduce malaria risk [10].
The utilization of ITNs and IPTp reduces malaria-related maternal and fetal complications. IPTp with sulfadoxine-pyrimethamine is associated with a reduced incidence of preterm delivery, spontaneous abortion, intrauterine fetal death, neonatal mortality, and low birth weight [11–13]. Insecticide-treated nets (ITNs) are also effective in reducing child mortality, parasite prevalence, and both uncomplicated and severe malaria episodes [14].Malaria prevention strategies in sub-Saharan African countries recommend that pregnant women use both ITNs and IPTp during pregnancy to reduce the risk of malaria infection [15–19].
Previous studies on malaria prevention measures, such as ITNs and IPTp, have revealed that factors including age, educational status, wealth index, marital status, sex of the household head, place of residence, and number of children are associated with the use of these malaria prevention measures [20–24].
Although numerous studies have examined the associated factors of malaria preventive measure utilization at the national level in African countries, most have focused on the use of either ITNs or IPT. However, few studies have considered the combined utilization of both ITNs and IPTp among pregnant women, despite the greater effectiveness of malaria prevention when both measures are used together [25, 26].
The combined use of insecticide-treated nets (ITNs) and intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) offers enhanced protection against malaria infection and anemia during pregnancy. Women who used both IPTp-SP and ITNs had a lower risk of malaria infection than those who used either intervention alone. Notably, malaria prevalence was higher in the IPTp-SP plus ITN group at the time of the first SP dose compared to the second and third doses, likely due to SP’s increasing effectiveness with repeated dosing and the added protection from continued ITN use [25–27].
Therefore, our study will fill this gap and be useful in strengthening malaria prevention implementation efforts in sub-Saharan African countries. This study aimed to identify and highlight factors that need improvement in the sub-Saharan African region to achieve the Global Technical Strategy for Malaria targets, including at least a 90% reduction in case incidence and mortality rates, and the elimination of malaria in 35 countries by 2030 [28].
Methods
Study area, design and population
We used recent data from the Malaria Indicator Survey (MIS) or Demographic and Health Survey (DHS) for eighteen sub-Saharan African (SSA) countries, selecting those with available outcome variables in surveys conducted after 2017 (Supplementary File 1). For countries with both DHS and MIS data, we generally used the most recent survey based on the year of data collection. However, for Kenya, we used the MIS data despite a more recent DHS being available, because the DHS lacked the outcome variable. The surveys included in this analysis were conducted between 2018 and 2024.The DHS and MIS employed a two-stage sampling method: stratified cluster sampling to select clusters from urban and rural areas, followed by systematic sampling to select households from the chosen clusters. This study included women who gave birth within three years preceding the survey. Since ITN utilization was only asked among women who had access to ITNs as per the DHS questionnaire our analysis focused on those with ITN access. Details of the inclusion and exclusion criteria are presented in the flowchart (Fig. 1). Individual countries contributed between 12% (Mali) and 2% (Liberia) of the weighted study sample. (Table 1).
Fig. 1.

Flow chart of study sample selection for the study on malaria prevention measures among pregnant women Sub-Sahara Africa (SSA), 2025
Table 1.
Frequency of study samples from 18 Sub-Sahara Africa countries for the study on malaria prevention measures utilization among pregnant women, 2025
| Country | Data | Survey year | Frequency unweighted (N = 64, 899) | Percentage (%) |
Frequency weighted (N = 63, 561) | Percentage (%) |
|---|---|---|---|---|---|---|
| Burkina Faso | DHS | 2021 | 5613 | 8.7 | 5535 | 8.7 |
| Cameroon | MIS | 2022 | 1983 | 3.1 | 1987 | 3.1 |
| Gabon | DHS | 2019/21 | 1660 | 2.6 | 1440 | 2.3 |
| Ghana | DHS | 2022 | 4155 | 6.4 | 3676 | 5.8 |
| Gambia | DHS | 2019/20 | 4.214 | 6.5 | 3770 | 5.9 |
| Guinea | MIS | 2021 | 1475 | 2.3 | 1474 | 2.3 |
| Kenya | MIS | 2020 | 1559 | 2.4 | 1395 | 2.2 |
| LIBERIA | MIS | 2022 | 1,334 | 2.1 | 1264 | 2.0 |
| Madagascar | DHS | 2021 | 5515 | 8.5 | 5374 | 8.4 |
| Mali | DHS | 2023/24 | 7113 | 10.9 | 7604 | 12.0 |
| Mauritania | DHS | 2019/21 | 3166 | 4.9 | 3146 | 5.0 |
| Mozambique | DHS | 2022/23 | 3277 | 5.1 | 3,344 | 5.3 |
| Nigeria | MIS | 2021 | 3567 | 5.5 | 3,831 | 6.0 |
| Niger | MIS | 2021 | 2613 | 4.0 | 2,770 | 4.4 |
| Sieraleone | DHS | 2019 | 4198 | 6.5 | 4,080 | 6.4 |
| SENEGAL | DHS | 2023 | 4010 | 6.2 | 3,478 | 5.5 |
| Tanzania | DHS | 2022 | 4828 | 7.4 | 4,848 | 7.6 |
| Zambia | DHS | 2018 | 4619 | 7.1 | 4,544 | 7.2 |
DHS- Demographic and Health Survey; MIS- Malaria Indicator Survey
Study variables
Outcome variable
The outcome variable, utilization of malaria preventive measures, was constructed as a composite measure derived from two survey items. The first item assessed ITN use, based on whether the respondent slept under a mosquito bed net the night before the survey. Responses were recoded into a binary variable: “Yes” if the respondent used only treated nets, and “No” if they used no net or only untreated nets. The second item assessed IPTp use, measured by the number of sulfadoxine-pyrimethamine (SP/Fansidar) doses received during pregnancy. A response was coded as “Yes” if the woman received three or more doses, indicating adequate IPTp coverage, and “No” if she received two or fewer doses.
Using these two binary indicators, a four-category outcome variable was created for multinomial regression. Women who used neither treated nets nor received at least three IPTp doses were classified as using no preventive methods (0); those who used treated nets but received fewer than three IPTp doses were categorized as using only ITNs (1); those who received three or more IPTp doses but did not use treated nets were categorized as using only IPTp (2); and women who both used treated nets and received three or more IPTp doses were classified as using both ITNs and IPTp (3).
Individual-level variables- age, educational status, marital status, wealth index, parity, sex of the household head, mass media exposure and Antenatal care visit.
Community level factors- residence and sub-region of SSA.
Operational definition
Mass media exposure was determined by combining three variables from the survey. Women were considered to have mass media exposure if they were exposed to magazines, radio, or television at least once per week. Otherwise, they were classified as having no mass media exposure.
Data management and statistical analysis
R 4.3 software was used for data extraction, cleaning, and management. All descriptive and analytical analyses were conducted using R and Stata 17. We weighted our sample before any analysis to account for the unequal selection probability of samples, following DHS guidelines.
DHS data has a clustered structure, with women nested within clusters. Women in the same cluster are more likely to share similar characteristics, violating the classical multinomial logistic regression assumption of independence of observations. To address this, we used a multilevel multinomial logistic regression model incorporating both fixed and random effects to account for the clustering of observations. We ran the multilevel multinomial regression model to identify both individual- and community-level determinants of malaria preventive measure utilization among pregnant women. The outcome category 'No preventive methods used' was used as the reference category for the multinomial regression analysis.
In the fixed-effects analysis, we first selected potential factors from the bi variable multinomial multilevel analysis based on a p-value <0.20 for the multivariable multinomial multilevel analysis. During the multilevel multinomial regression analysis, we assessed multi-collinearity among independent variables using the Variance Inflation Factor (VIF), considering variables with VIF >10 as having high multi-collinearity [29]. We fitted four multilevel multinomial models to identify determinants of malaria preventive measures utilization: the null model, which included only the outcome variable; Model 1, which included individual-level factors; Model 2, which incorporated community-level factors; and Model 3, which combined both individual- and community-level factors. After conducting the multivariable multilevel multinomial analysis, we reported the adjusted relative risk ratio (ARRR) with a 95% confidence interval. Variables with a p-value <0.05 or whose ARRR confidence interval did not include one were considered significantly associated with malaria preventive measures utilization among pregnant women.
To account for variability due to differences between clusters in our models, we reported the intra-class correlation coefficient (ICC) to indicate the proportion of total variability attributable to clustering. The ICC was calculated using the formula: ICC = σ2/ (σ2 + π2/3); σ2 is the variance between clusters. An ICC value greater than 0.10 indicated the presence of clustering, prompting us to use a mixed-effects model rather than a classical model for the analysis [30]. The Proportional Change in Variance (PCV) was used to assess the variation in model variance when different factors were included to explain the outcome. It was calculated using the formula: PCV = [(Va–Vb)/Va]*100; Va is the variance of the null model, and Vb is the variance of other consecutive models [30]. For model comparison, we reported the log-likelihood and deviance for each model. The best-fitting model was selected based on the highest log-likelihood and the lowest deviance.
Result
Background characteristics study participants
Our study included 63,561 weighted study participants who gave birth in the five years preceding the survey. The mean age of the participants was 28.2 years (SD ± 7.07). Among the participants, two-thirds (66.9%) lived in rural areas, more than one-third (39.1%) had not attended formal education, and more than 80% of household heads were male (Table 2).
Table 2.
Background characteristics of study participants for the study on malaria prevention measures utilization among pregnant women in Sub-Sahara Africa (SSA), 2025
| Variables | Frequency (N = 63,561) |
Percentage % |
|---|---|---|
| Age group (in years) | ||
| 15–19 | 6094 | 9.6 |
| 20–24 | 15,722 | 24.7 |
| 25–29 | 15,828 | 24.9 |
| 30–34 | 12,447 | 19.6 |
| 35–39 | 8825 | 13.9 |
| 40–44 | 3699 | 5.9 |
| 45–49 | 946 | 1.5 |
| Residence | ||
| Urban | 21,058 | 33.1 |
| Rural | 42,502 | 66.9 |
| Educational level | ||
| No education | 24,818 | 39.1 |
| Primary | 18,161 | 28.5 |
| Secondary | 18,066 | 28.4 |
| Higher | 2515 | 4.0 |
| Sex of household head | ||
| Male | 52,134 | 82.0 |
| Female | 11,427 | 18.0 |
| Wealth index | ||
| Poorest | 13,996 | 22.0 |
| Poorer | 13,924 | 21.9 |
| Middle | 13,067 | 20.6 |
| Richer | 12,109 | 19.1 |
| Richest | 10,465 | 16.5 |
| Parity | ||
| One | 14,134 | 22.2 |
| Two | 12,339 | 19.4 |
| Three or more | 37,088 | 58.4 |
| Mass media exposure | ||
| No | 43,717 | 68.8 |
| Yes | 19,844 | 31.2 |
| Antenatal care visit | ||
| No visits | 4210 | 6.6 |
| 1–3 visits | 18,696 | 29.4 |
| 4 or more visits | 40,654 | 64.0 |
Malaria preventive measures utilization of pregnant women in SSA countries
Among our weighted sample of 63,561 pregnant women, the utilization of malaria preventive measures was as follows: 28.9% (95% CI 28.4, 29.3%) used both insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp); 10.4% (95% CI 10.1, 10.7%) used only IPTp; and 43.2% (95% CI 42.7, 43.6%) used only ITNs (Fig. 2).
Fig. 2.

Malaria prevention measures utilization among pregnant women in Sub-Sahara Africa (SSA), 2025
Country-specific analysis revealed that Burkina Faso had the highest proportion and Mauritania had the lowest proportion of pregnant women utilizing both ITN and IPTp among sub-Saharan African (SSA) countries. In contrast, Mauritania had the highest proportion of pregnant women who utilized neither ITN nor IPTp (Fig. 3).
Fig. 3.

Malaria preventive measures utilization among pregnant women across Sub-Sahara Africa (SSA) countries, 2025
Factors associated with malaria prevention measures utilization
In the multilevel multivariable analysis, we modeled malaria prevention measures, including only ITN utilization, only IPTp utilization, and the combined use of ITN and IPTp, along with their factors among pregnant women. Model three, which includes both individual- and community-level factors, was identified as the best-fit model, as it had a higher log-likelihood and lower deviance; therefore, it was used as the final model (Table 3). Therefore, our findings are presented based on this model. A detailed comparison of all four models, including their log-likelihoods, deviances, other fit statistics, and aRRR estimates for the associated factors, is attached (see Supplementary Files 3 and 4).
Table 3.
Parameters of the final model for malaria preventive measures utilization among pregnant women in Sub-Sahara Africa (SSA), 2025
| Parameter | Final Model |
|---|---|
| Variance (95% CI) | 0.30 (0.24,0.37) |
| ICC | 0.09 |
| PCV | 0.37 |
| LL | − 76,467 |
| Deviance | 152934 |
ICC Intra-class correlation coefficient, PCV Proportional Change in Variance, LL Log-likelihood
ITN utilization was found to be significantly and positively associated with age, parity, mass media exposure, antenatal care visits, and rural residence, while it was negatively associated with educational status, female household head and wealth quantile. Significant differences were observed by sub-region of sub-Saharan Africa (SSA).
IPTp utilization showed a statistically significant positive association with a woman's age, educational status, wealth index, mass media exposure, and antenatal care visits, but was negatively associated with female household head and sub-region of SSA.
The utilization of both ITNs and IPTp was significantly and positively associated with a woman's age, mass media exposure, antenatal care visits, and rural residence, while it was negatively associated with educational status, female household head, wealth index, and sub-region of sub-Saharan Africa (SSA) (Table 4). This study primarily focused on the factors of combined malaria prevention method utilization, as the use of both ITNs and IPTp is highly effective in preventing malaria.
Table 4.
Multilevel multinomial regression of factors associated with malaria preventive measure utilization among pregnant women in Sub-Sahara Africa (SSA), 2025
| Variables | Final Model | ||
|---|---|---|---|
| Both community and individual level factors | |||
| ITN IPTp Both ITN and IPTp aRRR (95% CI) aRRR (95% CI) aRRR (95% CI) | |||
| Age group(in years) | |||
| 15–19 | 1 | 1 | 1 |
| 20–24 | 1.11 (1.01, 1.21)* | 1.05 (0.93, 1.19) | 1.25 (1.13, 1.38)** |
| 25–29 | 1.05 (0.95, 1.16) | 1.18 (1.04, 1.35)* | 1.36 (1.22, 1.52)** |
| 30–34 | 1.04 (0.93, 1.16) | 1.15 (0.99, 1.34) | 1.44 (1.28, 1.62)** |
| 35–39 | 0.98 (0.87, 1.09) | 1.14 (0.98, 1.34) | 1.34 (1.18, 1.52)** |
| 40–44 | 1.08 (0.94, 1.24) | 1.25 (1.03, 1.51)* | 1.45 (1.25, 1.68) ** |
| 45–49 | 0.87 (0.71, 1.08) | 0.93 (0.68, 1.27) | 1.31 (1.05, 1.64)* |
| Educational level | |||
| No education | 1 | 1 | 1 |
| Primary | 0.72 (0.68, 0.77)** | 0.95 (0.87, 1.04) | 0.78 (0.73, 0.84)** |
| Secondary | 0.79 (0.75, 0.85)** | 1.31 (1.20, 1.43)** | 0.97 (0.90, 1.04) |
| Higher | 0.68 (0.59, 0.78)** | 1.38 (1.17, 1.61)** | 0.81 (0.70, 0.93)** |
| Sex of household head | |||
| Male | 1 | 1 | 1 |
| Female | 0.70 (0.66, 0.74)** | 0.86 (0.79, 0.92)** | 0.69 (0.65, 0.74)** |
| Wealth index | |||
| Poorest | 1 | 1 | 1 |
| Poorer | 0.94 (0.87, 1.01) | 1.13 (1.02, 1.25)* | 0.99 (0.92, 1.07) |
| Middle | 0.96 (0.89, 1.04) | 1.10 (0.99, 1.23) | 1.01 (0.94, 1.09) |
| Richer | 0.95 (0.88, 1.03) | 1.01 (0.91, 1.14) | 0.91 (0.84, 0.99)* |
| Richest | 0.85 (0.77, 0.93)** | 1.05 (0.92, 1.19) | 0.82 (0.74, 0.90)** |
| Number of children | |||
| One | 1 | 1 | 1 |
| Two | 1.13 (1.05, 1.22)** | 1.01 (0.91, 1.11) | 1.06 (0.97, 1.15) |
| Three or more | 1.27 (1.17, 1.37)** | 0.93 (0.83, 1.03) | 1.04 (0.96, 1.14) |
| Mass media exposure | |||
| No | 1 | 1 | 1 |
| Yes | 1.15 (1.09, 1.21)** | 1.19 (1.11, 1.28)** | 1.28 (1.21, 1.35)** |
| Antenatal care visit | |||
| Less than four | 1 | 1 | 1 |
| Four and above | 1.16 (1.10, 1.22)** | 2.82 (2.63, 3.03)** | 3.49 (3.31, 3.69)** |
| Residence | |||
| Urban | 1 | 1 | 1 |
| Rural | 1.41 (1.32, 1.50)** | 0.92 (0.84, 1.01) | 1.39 (1.30, 1.49)** |
| Sub-region of SSA | |||
| Western | 1 | 1 | 1 |
| Eastern | 1.84 (1.71, 1.96)** | 0.74 (0.67, 0.82)** | 1.23 (1.14, 1.33)** |
| Central | 0.83 (0.75, 0.92)** | 0.99 (0.88, 1.13) | 0.83 (0.74, 0.92)** |
| South | 1.36 (1.25, 1.47)** | 1.74 (1.58, 1.92)** | 1.85 (1.70, 2.01)** |
*-P value < 0.05, ** -P value < 0.01, 1-reference category
CI Confidence interval, ITN Insecticide treated net, IPTp Intermittent preventive treatment for pregnant women, SSA Sub-Saharan Africa
Women aged 20 years and above were more likely to use both ITN and IPTp compared to those aged 15–19 years, with adjusted odds ratios across the 20 years and above age categories ranging from approximately 1.25–1.45.
Regarding educational level, pregnant women with primary education were 0.78 times (95% CI 0.73–0.84) less likely to utilize both ITN and IPTp compared to those with no formal education. Similarly, women with higher education had a 0.81 times (95% CI 0.70–0.93) lower likelihood of utilizing both ITN and IPTp than those with no formal education.
Women from female-headed households were 30% less likely (aRR = 0.69; 95% CI 0.65–0.74) to utilize both ITN and IPTp preventive measures compared to those in male-headed households.
Mass media exposure, antenatal care (ANC) visits, rural residence, and being from the Eastern and Southern sub-regions of SSA were all associated with a higher likelihood of utilizing both ITN and IPTp measures (Table 4).
In addition, we conducted a country-stratified analysis to examine significant factors across countries. Among these, antenatal care (ANC) visits were consistently and positively associated with the utilization of both ITN and IPTp. Details on other associated factors for each country are presented in the figure (Fig. 4).
Fig. 4.

Country stratified analysis for associated factors of Both ITN and IPTp utilization among pregnant women in Sub-Sahara Africa (SSA), 2025
Discussion
This study aimed to assess the utilization of both ITN and IPTp measures, as well as their associated factors, among pregnant women in sub-Saharan Africa. The findings showed that 82% of women used at least one preventive measure (either ITNs or IPTp), while 29% used both ITNs and IPTp. In contrast, 18% of pregnant women did not use any malaria prevention methods (neither ITN nor IPTp). In the multilevel multinomial regression analysis, factors such as women's age, educational status, ANC visit, sex of the household head, wealth index, mass media exposure, place of residence, and sub-region within sub-Saharan Africa were identified as significant factors of ITN and IPTp utilization.
Only one-third of pregnant women utilized both ITN and IPTp, and those who did not use both measures missed out on the synergistic benefits of ITN and IPTp. The utilization of both ITN and IPTp in this study is higher than in previous studies [31–33]. One possible explanation for this difference could be the variation in study periods and differences in the operational definitions of IPTp uptake. In this study, IPTp utilization was defined as receiving at least three dose of sulfadoxine-pyrimethamine during pregnancy.
Women aged 20–49 years were more likely to use both ITN and IPTp compared to those aged 15–19 years, as supported by another study [34]. This may be because older women often have more experience with antenatal care (ANC) visits and more frequent interactions with healthcare providers, such as during family planning services. These encounters increase their exposure to health education on malaria prevention. Furthermore, older women may feel more confident in making informed health decisions, which can lead to greater adoption of malaria prevention measures.
Women with primary education were less likely to use both insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp) compared to those who did not attend formal education. This finding may be due to that women with no formal education are often more reliant on public health services, where ITNs and IPTp are provided free of charge during antenatal care. They may also be more likely to follow health professionals’ advice strictly, without questioning or seeking alternative sources of information. In contrast, women with primary education might feel a degree of autonomy in health-related decision-making but may not yet have sufficient health literacy to fully understand the importance of malaria prevention interventions during pregnancy.
Women from female-headed households were less likely to use both ITN and IPTp compared to those from male-headed households. One possible explanation is that male-headed households are often associated with more authoritative decision-making, where rules and health-related choices, including the use of ITN and IPTp, may be more strictly enforced. In contrast, female-headed households might experience more flexibility in these decisions, potentially leading to lower utilization of these preventive measures [35–37]. Another reason could be the gender-related inequality in the SSA region, where women and girls have unequal access to education and economic opportunities [38].
Women in the poorer, middle, or richer wealth categories were less likely to use both ITNs and IPTp compared to those in the poorest category. One possible explanation is that women from the poorest households are more likely to rely on public health services-where ITNs and IPTp are routinely provided free of charge during antenatal care visits-due to higher perceived risk. In contrast, wealthier women may seek care in private facilities, where malaria prevention may not be consistently integrated into routine maternal services. Additionally, public health campaigns often target low-income and rural communities where malaria transmission is highest more intensively, thereby increasing awareness and uptake of government-provided preventive interventions among the poorest groups [39].
Antenatal care (ANC) attendance plays a crucial role in increasing the uptake of insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp) among pregnant women. Women who attend ANC visits regularly are more likely to receive health education from trained professionals, which raises their awareness of malaria risks and the benefits of preventive measures [40, 41]. In many countries, ITNs are also distributed during ANC visits, and IPTp is provided as well, further facilitating access and utilization. Additionally, the trust established between pregnant women and healthcare providers during ANC visits can encourage consistent adherence to recommended malaria prevention practices.
Women who had mass media exposure were more likely to use both ITN and IPTp compared to those who did not, which is consistent with findings from other studies [42, 43]. This may be because mass media serves as a primary channel for disseminating health education initiatives, including malaria prevention campaigns, to a broad audience. Therefore, exposure to mass media platforms such as television and radio plays a crucial role in influencing the adoption of ITN and IPTp.
Women from rural areas were more likely to use both insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp) compared to their urban counterparts. This may be partly explained by rural women’s greater reliance on public health services and their adherence to the advice and guidance provided by health professionals during antenatal care visits. Additionally, targeted distribution campaigns for malaria prevention tools, such as mass ITN distributions, are often prioritized in rural and high-transmission areas, further increasing access and utilization in these settings [44].
From a programmatic perspective, increasing the proportion of pregnant women who utilized both IPTp and ITNs was highly relevant for malaria prevention programs. In our pooled analysis, 71.1% of women did not utilize both interventions, and these women fell into distinct subgroups (only ITN, only IPTp, or none), underscoring the need for tailored strategies. Our country-level findings also revealed substantial heterogeneity in the factors associated with both ITN and IPTp: while ANC uptake consistently showed a positive association across all settings, other factors varied considerably between countries. To enhance coverage of both interventions, national programs might therefore have benefited from more in-depth exploration of their own data to identify context-specific barriers. Such insights could have guided the design and implementation of targeted approaches to move women from utilizing one or no intervention to utilizing both ITN and IPTp.
This analysis used nationally representative Malaria Indicator Survey (MIS) data from multiple countries. The large sample size, combined with the use of standardized and validated data collection instruments and methodologies, enhances the generalizability of the findings. To account for the clustering effect inherent in the data, a multilevel modeling technique was employed. IPTp utilization was assessed based on the World Health Organization's (WHO) recommendation of at least three doses. Nevertheless, the study has some limitations. First, the cross-sectional design precludes the establishment of causal relationships between the outcome and explanatory variables. Second, reliance on self-reported data introduces the potential for recall bias. Third, the analysis was conducted using national-level data for each country. However, in some countries, such as Kenya, malaria prevention policies targeting IPTp interventions are implemented only in specific geographic areas, which may have affected the national-level indicators.
Conclusion
Pregnant women in the Sub-Saharan African region utilize both ITN (Insecticide-Treated Nets) and IPTp (Intermittent Preventive Treatment in pregnancy) at a rate of 29%. The study identified several significant factors influencing ITN and IPTp utilization, including women's age, educational status, number of ANC (Antenatal Care) visits, sex of the household head, wealth index, mass media exposure, place of residence, and sub-region within Sub-Saharan Africa.
Therefore, special attention should be given to those with fewer than four ANC visits and to younger women, especially first-time pregnant women whose utero-placental interface has not previously been exposed to malaria parasites, making them more susceptible, as well as to those with no mass media exposure, residents of urban areas, and households headed by females during malaria prevention interventions. However, our country-level analysis demonstrated substantial variation in the influence of these factors across countries, underscoring the need for national programs to interpret and adapt these findings to their specific contexts. Both individual and community level factors must be considered when developing strategies and implementing programs led by governmental and non-governmental organizations. This comprehensive and context-sensitive approach is essential for achieving the global goal of reducing malaria by 90% by 2030.
Supplementary Information
Acknowledgements
We acknowledge the MEASURE DHS Program for permitting us to use the MIS data.
Abbreviations
- ANC
Antenatal care
- ARR
Adjusted relative risk
- DHS
Demographic and health survey
- ITN
Insecticide treated net
- IPTp
Intermittent preventive treatment for pregnant women
- ICC
Intra class correlation
- PCV
Proportional change in variance
- LL
Log likelihood
- MIS
Malaria indicator survey
- SDG
Sustainable development goal
- SSA
Sub-Saharan africa and
- WHO
World Health Organization
Author contributions
EAA-developed the concept, reviewed literature, carried out the statistical analysis, interpret and discuss the results, and write the final manuscript. MAT, TYB, SGD, GY, LD and AAT -reviewed literature, involved in the analysis, interpreting and discussing results, and revised the drafted manuscript. All authors read and approved the final manuscript.
Funding
No funding.
Data availability
The data that the authors used to produce this manuscript are available upon reasonable request from demographic and health survey (DHS) cite). (www.dhsprogram.com) The DHS Program is authorized to distribute, at no cost, unrestricted survey data files for legitimate academic research. Registration is required for access to data.
Declarations
Ethics approval and consent to participate
Not applicable—consent from participants is not required since a publicly available dataset was used. Permission to access the data was obtained from the Measure DHS Program (www.dhsprogram.com) via an online request after explaining the purpose of the study. The website and the data used are publicly available and contain no personal identifiers. All methods were carried out in accordance with relevant guidelines and regulations. The DHS also confirmed that informed consent was obtained from all subjects and/or their legal guardians during the primary data collection.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
The original online version of this article was revised: the spelling error in the author's name Asefa Adimasu Taddese has been corrected.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Change history
8/25/2026
A Correction to this paper has been published: 10.1186/s12936-026-06109-2
References
- 1.Yin J, Zhang T, Liu Y, Li J, Huang Y. Prevention of re-establishment of malaria transmission in China: insights from the world malaria report 2025. Zoonoses. 2026;6(1):986. [Google Scholar]
- 2.Yitageasu G, et al. Malaria prevalence and its determinants across 19 sub-Saharan African countries: a spatial and geographically weighted regression analysis. Malar J. 2025;24(1):305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Minwuyelet A, et al. Current update on malaria in pregnancy: a systematic review. Trop Dis, Travel Med Vacc. 2025;11(1):14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mbacham WF, Ayong L, Guewo-Fokeng M, Makoge V. Current situation of malaria in Africa. InMalaria control and elimination 2019 Jul 3 (pp. 29-44). New York, NY: Springer New York. [DOI] [PubMed]
- 5.Ukaegbu EO. Malaria in pregnancy 2020.
- 6.Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004;17(4):760–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Moore KA, et al. Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(11):e1101–12. [DOI] [PubMed] [Google Scholar]
- 8.Oladipo HJ, et al. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Annals of Medicine and Surgery. 2022;81:104366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. Regional Office for Africa: World Health Organization; 2004. [Google Scholar]
- 10.World Health Organization. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). World Health Organization; 2014.
- 11.Desai M, et al. Prevention of malaria in pregnancy. Lancet Infect Dis. 2018;18(4):e119–32. [DOI] [PubMed] [Google Scholar]
- 12.Godwin IO, et al. Effectiveness of antenatal intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine on peripartum outcomes. Ther Adv Infect Dis. 2022;9:20499361221122620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Menéndez C, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS ONE. 2010;5(2):e9438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pryce J, Richardson M, Lengeler C. Insecticide‐treated nets for preventing malaria. Cochrane Database of Systematic Reviews. 2018. [DOI] [PMC free article] [PubMed]
- 15.Otambo WO, Olumeh JO, Ochwedo KO, Magomere EO, Debrah I, Ouma C, et al. Health care provider practices in diagnosis and treatment of malaria in rural communities in Kisumu County, Kenya. Malaria J. 2022;21(1):129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Cissoko M, Magassa M, Cissé IA, Coulibaly S, Samaké DS, Sanogo V, et al. Geo-epidemiological risk stratification to select malaria interventions, case of Mali. PLOS Global Public Health. 2025;5(11):e0004796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Millogo AA, Yaméogo L, Paré Toé L, Zerbo R, Ouédraogo FD, Diabaté A. Assessment of community-based resilience to malaria in two transmission settings in Western Burkina Faso. BMC Public Health. 2025;25(1):820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Runge M, Snow RW, Molteni F, Thawer S, Mohamed A, Mandike R, et al. Simulating the council-specific impact of anti-malaria interventions: a tool to support malaria strategic planning in Tanzania. PLoS ONE. 2020;15(2):e0228469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.President's Malaria Initiative E. malaria operational plan FY 2018. Addis Ababa: USAID. 2018.
- 20.Chukwu C, et al. Geopolitical zones differentials in intermittent preventive treatment in pregnancy (IPTp) and long lasting insecticidal nets (LLIN) utilization in Nigeria. PLoS ONE. 2021;16(7):e0254475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Buh A, et al. Prevalence and associated factors of taking intermittent preventive treatment in pregnancy in Sierra Leone. Trop Med Infect Dis. 2019;4(1):32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Eshetu B, et al. Insecticide-treated net utilization and associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis. Frontiers in Global Women’s Health. 2023;4:1147583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Anikwe CC, et al. Long‐lasting insecticide‐treated nets: Assessment of the awareness and utilization of them among antenatal clinic attendees in Abakaliki, Southeast Nigeria. J Trop Med. 2020;2020(1):2984867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ibrahim H, et al. Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani Municipality, Ghana. Pan Afr Med J. 2017;28:122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Fokam EB, et al. Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon. Malar J. 2016;15(1):172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ugboaja JO, Oguejiofor CO. Efficacy of intermittent preventive treatment and insecticide treated nets on malaria parasitaemia in pregnancy among Igbo women in southeastern Nigeria. J Vector Borne Dis. 2017;54(3):249–54. [DOI] [PubMed] [Google Scholar]
- 27.Madukwe JC, et al. Do women attending antenatal clinics who use only intermittent preventive treatment (IPTp) have higher Plasmodium falciparum prevalence compared to those who used both IPTp and slept under insecticide-treated nets? Malar J. 2025;24(1):275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.A report of the Strategic Advisory Group on Malaria Eradication. Malaria eradication: benefits, future scenarios and feasibility. World Health Organization; 2020. [Google Scholar]
- 29.Kutner MH, et al. Applied linear statistical models. McGraw-hill; 2005. [Google Scholar]
- 30.Merlo J, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: Using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bello F, Ayede A. Prevalence of malaria parasitaemia and the use of malaria prevention measures in pregnant women in Ibadan, Nigeria. Ann Ibadan Postgrad Med. 2019;17(2):124–9. [PMC free article] [PubMed] [Google Scholar]
- 32.Barry I, et al. Variations in the use of malaria preventive measures among pregnant women in Guinea: A secondary analysis of the 2012 and 2018 demographic and health surveys. Malar J. 2022;21(1):309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Mbengue MAS, et al. Factors influencing the use of malaria prevention strategies by women in Senegal: a cross-sectional study. Malar J. 2017;16:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mwandama D, et al. The use of intermittent preventive treatment in pregnancy and insecticide-treated bed nets for malaria prevention by women of child-bearing age in eight districts in Malawi. Malar J. 2015;14(1):316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ameyaw EK. Individual, community and societal correlates of insecticide treated net use among pregnant women in sub-Saharan Africa: a multi-level analysis. BMC Public Health. 2021;21:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Fokam EB, et al. Determination of the predictive factors of long-lasting insecticide-treated net ownership and utilisation in the Bamenda Health District of Cameroon. BMC Public Health. 2017;17(1):263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tadesse EM, Baruda YS, Tadesse TM. Assessment of household insecticide-treated bed net ownership, utilization, and associated factors in Kersa Woreda, Jimma Zone, Southwest Ethiopia. J Health Popul Nutr. 2024;43(1):214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.World Health Organization. WHO technical brief for countries preparing malaria funding requests for the Global Fund (2020–2022). World Health Organization; 2020
- 39.Okova D, et al. Between-and within-socioeconomic groups temporal inequality in the uptake of malaria prevention strategies among pregnant women and under-five children in Ghana (2003–2022). Malar J. 2025;24(1):273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Atser PN, Hayat G, Okafor UB. Effect of health education intervention on knowledge and adherence to intermittent preventive treatment of malaria in pregnancy among women. InHealthcare 2025 Jan 8 (Vol. 13, No. 2, p. 105). MDPI. [DOI] [PMC free article] [PubMed]
- 41.Leonard N, et al. Factors associated to the use of insecticide treated nets and intermittent preventive treatment for malaria control during pregnancy in Cameroon. Archives Public Health. 2016;74(1):5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Darteh EKM, et al. Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis. Archives Public Health. 2021;79(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ankomah A, Adebayo 1, Arogundade ED, Anyanti J, Nwokolo E, Inyang U, Ipadeola OB, Meremiku M. The Effect of Mass Media Campaign on the Use of Insecticide‐Treated Bed Nets among Pregnant Women in Nigeria. Malaria research and treatment 2014(1): 694863. [DOI] [PMC free article] [PubMed]
- 44.Niguse W, et al. Low ITN utilization among households in SWEPR Ethiopia: challenge for malaria elimination, a mixed design approach. BMC Public Health. 2025;25(1):472. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that the authors used to produce this manuscript are available upon reasonable request from demographic and health survey (DHS) cite). (www.dhsprogram.com) The DHS Program is authorized to distribute, at no cost, unrestricted survey data files for legitimate academic research. Registration is required for access to data.
